Correlation Between Visa and Paratek Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Visa and Paratek Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Paratek Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Paratek Pharmaceuticals, you can compare the effects of market volatilities on Visa and Paratek Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Paratek Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Paratek Pharmaceuticals.

Diversification Opportunities for Visa and Paratek Pharmaceuticals

0.0

Correlation Coefficient

Visa  Paratek Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Visa and Paratek is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Paratek Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paratek Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Paratek Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paratek Pharmaceuticals has no effect on the direction of Visa i.e., Visa and Paratek Pharmaceuticals go up and down completely randomly.

Pair Corralation between Visa and Paratek Pharmaceuticals

If you would invest  31,812  in Visa Class A on December 27, 2024 and sell it today you would earn a total of  2,606  from holding Visa Class A or generate 8.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Visa Class A  vs.  Paratek Pharmaceuticals

Visa Class A

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Paratek Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Paratek Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Paratek Pharmaceuticals is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Visa and Paratek Pharmaceuticals

The main advantage of trading using opposite Visa and Paratek Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Paratek Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paratek Pharmaceuticals will offset losses from the drop in Paratek Pharmaceuticals' long position.

The idea behind Visa Class A and Paratek Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.